Trial · NCT04459767
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 23
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of treatment related adverse events | Day 0-90 | |
| Primary | Incidence of abnormal and clinically relevant changes in electrocardiogram | Day 0-90 | |
| Primary | Incidence and magnitude of abnormal laboratory findings | Day 0-90 | |
| Primary | Incidence of abnormal and clinically relevant changes in pulse rate | Day 0-90 | |
| Primary | Incidence of abnormal and clinically relevant changes in supine blood pressure | Day 0-90 | |
| Secondary | Maximum observed plasma concentration (Cmax) | Day 0-90 | |
| Secondary | Time to reach maximum observed plasma concentration (Tmax) | Day 0-90 | |
| Secondary | Area under the plasma concentration-time profile from time zero to 24 hours post-dose (AUC24h) | Day 0-90 | |
| Secondary | Area under the plasma concentration-time profile from time zero to 48 hours post-dose (AUC48h) | Day 0-90 | |
| Secondary | Area under the plasma concentration-time profile from time zero to the last measurable concentration (AUClast) | Day 0-90 | |
| Secondary | Area under the plasma concentration-time profile from time zero to infinity (AUCinf) | Day 0-90 | |
| Secondary | Terminal elimination half life (t1/2) | Day 0-90 | |
| Secondary | Apparent volume of distribution (Vz/F) | Day 0-90 | |
| Secondary | Apparent clearance (CL/F) | Day 0-90 | |
| Secondary | Percentage changes from baseline in serum angiopoietin-like protein 3 | Day 0-90 | |
| Secondary | Percentage changes from baseline in total cholesterol | Day 0-90 | |
| Secondary | Percentage changes from baseline in low density lipoprotein cholesterol | Day 0-90 | |
| Secondary | Percentage changes from baseline in non-high-density lipoprotein cholesterol | Day 0-90 | |
| Secondary | Percentage changes from baseline in very low density lipoprotein cholesterol | Day 0-90 | |
| Secondary | Percentage changes from baseline in triglyceride | Day 0-90 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04459767/registered